The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so
Topics
Meeting category
Date(s)
7 Jun 2022 - 8 Jun 2022
Program Language
English
Meeting type
Virtual
Organizer
International Workshop on COVID-19 Vaccines 2022 - June Edition
Related Enduring Materials
Enduring Materials
Day 1 - Tuesday, 7 June
Opening: COVID-19 Vaccine Development - 17:00 CEST -
Kathryn Stephenson, MD, MPH
COVID-19 Vaccines - State of the Art
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
Session 1: COVID-19 Vaccination Strategies to Control COVID-19 - 17:35 CEST -
17:35 CEST
Immune Correlates of Protection from SARS-CoV-2 Infection
17:50 CEST
Defining Goals for COVID-19 Vaccination
18:05 CEST
Infection-Induced and Hybrid Immunity
Session 2: COVID-19 Vaccine Safety - 19:00 CEST -
Ai-ris Yonekura Collier, MD
19:00 CEST
Myocarditis and COVID-19 Vaccination
19:15 CEST
Thrombosis and COVID-19 Vaccination
19:30 CEST
COVID-19 Vaccination in Pregnant and Lactating Individuals
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, United States
Oral Abstract Presentation Session - 20:15 CEST -
20:23 CEST
Novel Vaccination Strategies Using Protein Based Microparticulate Vaccine for COVID-19 (#2)
Smital Patil
United States
Day 2 - Wednesday, 8 June
Session 3: COVID-19 Vaccination Policies and Hesitancy - 17:00 CEST -
Margie Danchin, MBBS PhD FRACP
17:05 CEST
Conversations in the Clinic and Community: How to Convey Messages about Vaccine Safety
University of Melbourne and Murdoch Children’s Research Institute (MCRI), Australia
Debate: Vaccine Mandates are Key to Fighting COVID-19 - 17:20 CEST -
Jeffrey V. Lazarus, PhD, MIH, MA
17:24 CEST
PRO
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
17:32 CEST
CON
Session 4: Panel Discussion on Regional perspectives of COVID-19 Vaccines - 18:20 CEST -
18:20 CEST
Perspectives from Africa
18:25 CEST
Perspectives from Asia
18:30 CEST
Perspectives from Latin America
Session 5: COVID-19 Vaccines in Immunocompromised and High-Risk Patients - 19:05 CEST -
Anna Maria Geretti, MD, PhD, FRCPath
Camille Kotton, MD, FIDSA, FAST
19:05 CEST
Strategies to Vaccinate Immunocompromised Patients
University of Rome, Italy / King's College London, United Kingdom
19:20 CEST
Vaccination in Immunocompromised Patients: How to Optimize Protection
Massachusetts General Hospital, Harvard Medical School, United States
Oral Poster Presentations Session - 20:00 CEST -
Chair
20:00 CEST
COVID-19 Vaccine Hesitancy Among Healthcare Providers in 23 Countries (#7)
Trenton White
Spain
20:09 CEST
A Survey on Factors Influencing COVID-19 Vaccine Hesitancy in the Bamenda-Cameroon (#9)
Lem Edith Abongwa
Cameroon
20:15 CEST
Understanding Motivators and Barriers to Taking the COVID-19 Vaccine Among Vaccinated and Unvaccinated Participants in Zimbabwe (#10)
Cleopatra Makura
Zimbabwe
20:21 CEST
Enablers and Perceived Risks of Covid-19 Vaccine Uptake Among Health Care (#11)
Valentine Obidile
Nigeria
20:27 CEST
SARS-CoV-2 Infection Among Vaccinated Healthcare Workers in Bulgaria (#12)
Reneta Dimitrova
Bulgaria
20:33 CEST
COVID-19 Vaccine Acceptance and Decision-Making Among Healthcare Workers in Four Provinces, South Africa: a Qualitative Study (#13)
Lerato Makhale
South Africa
20:39 CEST
COVID-19 Vaccine Knowledge and Acceptability Among Healthcare Providers in Nigeria (#14)
Onyeka Ekwebene
Nigeria
End of the Workshop
Overview
Image
About this Program
The third edition of the International Workshop on COVID-19 Vaccines 2022 took place from 7 - 8 June 2022 as a virtual program.
Despite the incredible success that vaccines have had in preventing COVID-19 and saving lives, there are still many knowledge gaps to be addressed for improved pandemic preparedness. The International Workshop on COVID-19 Vaccines 2022 aims to increase knowledge and facilitate discussion on the many aspects of SARS-CoV-2 vaccines among virologists, infectious diseases specialists, community, and policymakers. Emerging clinical data, the impact of vaccination and boosting on COVID-19 country rates, the durability of immunity, vaccine safety and side effects, vaccines in children, pregnancy as well as high risk patients, and the impact of new virus variants on protection are just a few of the topics that are covered in this workshop.
This was done in the truly global context of the COVID-19 pandemic, considering regional differences in access to vaccines, health systems, public health policies and hesitancy to vaccinations.
The first two editions of this workshop were exceptionally successful in gathering experts and discussing the many aspects of vaccine development and rollout in 2021.
Program Directors
General Information
Who Should Attend?
- Virologists, immunologists, and scientists involved or interested in vaccine research and physicians caring for COVID-19 patients;
- Nurses, and other healthcare professionals involved in the care of COVID-19; patients, policymakers, and (non)government representatives; and
- Healthcare administrators.
- Nurses, and other healthcare professionals involved in the care of COVID-19; patients, policymakers, and (non)government representatives; and
- Healthcare administrators.
Meeting Objectives
-Create a platform for scientific exchange and discussion around COVID-19 vaccines;
-Outline challenges related to COVID-19 vaccination policies and hesitancy;
-Provide a platform to discuss regional aspects of COVID-19 vaccines.
-Outline challenges related to COVID-19 vaccination policies and hesitancy;
-Provide a platform to discuss regional aspects of COVID-19 vaccines.
Learning Objectives
At the completion of the program participants will be able to:
-Describe the latest developments on COVID-19 vaccines;
-Define correlates of protection for COVID-19 vaccines;
-Outline side effects and safety of COVID-19 vaccines;
-Reflect on COVID-19 vaccination policies, and how to communicate messages about vaccine safety;
-Be updated on equal roll-out and regional aspects of COVID-19 vaccines; and
-Evaluate COVID-19 vaccination in key populations: high risk patients, pregnant and breastfeeding individuals.
-Describe the latest developments on COVID-19 vaccines;
-Define correlates of protection for COVID-19 vaccines;
-Outline side effects and safety of COVID-19 vaccines;
-Reflect on COVID-19 vaccination policies, and how to communicate messages about vaccine safety;
-Be updated on equal roll-out and regional aspects of COVID-19 vaccines; and
-Evaluate COVID-19 vaccination in key populations: high risk patients, pregnant and breastfeeding individuals.
Practical Information
We trust that the following information will assist you in organizing your participation for the International Workshop on COVID-19 Vaccines 2022 - June Edition.
Certificate of Attendance
A digital certificate of attendance will be sent to participants that have successfully completed the program and post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Disclaimer
This program is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organising Secretariat of this program, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this program. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the program.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Support
The International Workshop on COVID-19 Vaccines 2022 was supported by:
Gold Level Support
The International Workshop on COVID-19 Vaccines 2022 was supported by a grant from Pfizer Inc.
Endorsers
The International Workshop on COVID-19 Vaccines 2022 was endorsed by the following organizations:
Previous Editions
Top-Rated Materials from Previous Editions
How to Assess Protection Against Infection and Transmission After Vaccination? - Monica Gandhi, MD, MPH
COVID-19 Vaccine Development & Implementation Workshop 2021 - June Edition
Language
Related Programs
